Is Myelodysplastic Syndrome Hereditary?

Most cases of myelodysplastic syndrome are not inherited. The large majority arise from acquired gene changes that build up in bone marrow cells during a person’s life, not from a faulty gene passed down from a parent. That said, a small number of families carry inherited gene variants that clearly raise the risk, and doctors can often tell the difference with the right tests.

Is Myelodysplastic Syndrome Hereditary?

For the general population, the answer is no. Myelodysplastic syndrome, usually called MDS, is a group of bone marrow disorders in which blood-forming cells become abnormal and stop maturing properly. The result is low counts of healthy red cells, white cells, or platelets, and a risk that the abnormal cells may progress to acute myeloid leukemia.

In the great majority of people diagnosed with MDS, no inherited cause is found. The gene changes driving the disease are somatic, meaning they happened in a single blood-forming cell sometime during life and are not present in the person’s other cells or in their children. These changes are not passed to offspring.

A minority of cases do run in families. When MDS appears in multiple blood relatives, especially at younger ages, doctors consider an inherited predisposition syndrome. These syndromes are uncommon but real, and identifying them changes how a family is monitored and counseled.

What Causes MDS If It Is Not Inherited?

MDS is fundamentally a disease of accumulated gene damage in bone marrow stem cells. Over years, a blood-forming cell picks up mutations that disrupt how it grows and matures. When enough of these changes collect, the marrow starts producing defective blood cells.

Several factors are linked to a higher chance of developing MDS:

• Older age. Risk rises steadily after age 60, and the median age at diagnosis in the United States is in the late 60s to early 70s.
• Prior chemotherapy or radiation for another cancer. This is called therapy-related MDS and can appear years after treatment.
• Long-term exposure to certain industrial chemicals, including benzene.
• Smoking, which is associated with an increased risk.
• Certain inherited bone marrow failure syndromes.

Most people who develop MDS have none of these specific exposures. In those cases, the disease reflects the random accumulation of mutations that comes with aging. This is why MDS becomes more common as people get older.

One clarification worth making: MDS is not contagious, and it is not caused by lifestyle choices in any simple sense. It is also not the same as a low blood count from a temporary cause like infection or nutritional deficiency, even though the lab numbers can look similar.

Which Inherited Conditions Raise the Risk of MDS?

A handful of inherited syndromes carry a meaningfully higher lifetime risk of MDS and related blood cancers. These are the situations where the word hereditary genuinely applies.

• DDX41-associated predisposition. This is one of the more recently recognized inherited causes of MDS and is now considered among the more common familial forms in adults. It runs in an autosomal dominant pattern, meaning a parent with the variant has a 50 percent chance of passing it to each child.
• GATA2 deficiency. An inherited condition that affects the immune system and bone marrow and raises the risk of MDS and leukemia.
• RUNX1 familial platelet disorder. A syndrome that causes low platelets and a higher risk of MDS and leukemia.
• Fanconi anemia, dyskeratosis congenita, and Shwachman-Diamond syndrome. Inherited bone marrow failure syndromes that can progress to MDS.
• Li-Fraumeni syndrome and other cancer predisposition syndromes. Some inherited cancer syndromes include an elevated risk of blood cancers.

These conditions are individually rare. Together they account for a small share of all MDS. But when they are present, the implications for the patient and the family are significant, which is why recognizing them matters.

When Should You Suspect an Inherited Cause?

Certain patterns should prompt a doctor to look for an inherited predisposition rather than assume the disease is sporadic.

• MDS diagnosed at a relatively young age, particularly under 50.
• Two or more close blood relatives with MDS, acute myeloid leukemia, or related blood cancers.
• A personal or family history of unusually low blood counts, easy bruising, or bleeding that goes back years.
• Other physical features or a family history suggesting an inherited bone marrow failure syndrome.
• Certain findings on genetic testing of the marrow that are known to appear in inherited forms.

None of these findings proves an inherited cause on its own. They are signals to investigate further. A genetic counselor or a hematologist familiar with inherited blood disorders can guide the evaluation.

How Is an Inherited Risk Actually Tested?

The key test is germline genetic testing. A germline test looks at DNA from cells that are not part of the cancer, usually from a blood sample, a cheek swab, or skin. If a disease-causing variant shows up in that sample, it means the variant is present throughout the body and could be passed to children.

This is different from testing the bone marrow itself. Marrow testing looks for the acquired mutations that are driving the disease in the blood cells. Those mutations are usually not inherited. Distinguishing germline from acquired mutations is the central question in sorting out whether MDS is hereditary in a given person.

A complication worth knowing: sometimes a mutation appears in both the marrow and the germline sample. In that case it is inherited. Sometimes it appears only in the marrow. In that case it is acquired. Careful testing of both sample types is what allows doctors to tell the difference.

Genetic testing is typically done when the family history or the patient’s age and features raise suspicion. It is not recommended for everyone with MDS. A genetic counselor can explain the possible results, what they mean for relatives, and the limits of what testing can tell you.

What Does an Inherited Risk Mean for Family Members?

If a germline variant that raises MDS risk is found, first-degree relatives — parents, siblings, and children — may be offered testing. Whether they should be tested depends on the specific variant and how it is inherited.

Some inherited predisposition syndromes follow an autosomal dominant pattern, so each child of an affected parent has a 50 percent chance of inheriting the variant. Others follow different patterns. A genetic counselor can explain the specifics for a given family.

For relatives who carry a risk variant, doctors may recommend regular blood count monitoring so that any changes are caught early. For those who do not carry it, the elevated risk generally does not apply, and they can be reassured on that point.

One honest limitation: carrying a risk variant does not mean a person will definitely develop MDS. It means the risk is higher than average. Many people with these variants never develop the disease. Predicting who will and who will not is not currently possible.

Does MDS Pass From Parent to Child Directly?

No. MDS itself is not passed from parent to child. What can be inherited is a predisposition — a gene variant that raises the chance of developing MDS later in life. The disease still has to develop, which usually requires additional acquired mutations.

This distinction matters. A parent with MDS does not hand the disease to a child. In the uncommon inherited syndromes, a parent may pass on a risk variant, and the child may or may not go on to develop MDS. In the far more common sporadic cases, there is no inherited component at all, and children face no elevated risk from their parent’s diagnosis.

What This Means for Most People With MDS

If you or a loved one has been diagnosed with MDS and there is no family history and no unusually young age at diagnosis, the most likely explanation is that the disease arose from acquired mutations. In that situation, the diagnosis is not considered hereditary, and relatives are not at increased risk because of it.

If there is a family pattern, a young age at diagnosis, or other features that raise suspicion, it is reasonable to ask a hematologist whether germline testing is warranted. That conversation is worth having, because the answer can affect monitoring for the whole family.

The evidence on inherited MDS has grown substantially in recent years, and several of the syndromes listed above were recognized only in the past decade or two. Testing options have expanded alongside that understanding. For families with a clear pattern, that progress has real practical value.